Your risk of acquiring migraine as an adult may be affected by hormone levels in the womb before you are born, according to a new study released today in the journal Pain Research. Researchers at the University of California, San Diego (UCSD) utilized the world’s biggest database of twins to evaluate the role of the prenatal atmosphere on sex distinctions in migraine risk. The research also implies that genes that impact migraine risk may be distinct in men and women. Migraine is 2 to 3 times more prominent in women than men. The condition is relatively ordinary, impacting about 12 percent of trusted sources of the entire population. The researchers had speculated that having a male co-twin would decrease the chance of migraine in females. Rather, the analysis exhibited a rise in risk comparative to females with a female co-twin. Data for the research came from 51,872 participants in the Swedish Twin Registry. It encompassed evidence on same-sex identical and fraternal twins, as well as opposite-sex fraternal twins.
AIIMS and IIT Delhi join forces to address a long-standing issue
There was no data considering the age at onset of migraine, so hormonal changes such as puberty could not be analyzed. The study writers hope their analysis will steer to more beneficial and targeted therapies for migraine. “The findings of our study are important because the more we understand the factors that contribute to migraine, and especially the differences between males and females, the more opportunity there is to improve clinical care, diagnostic abilities, and therapeutic interventions for both men and women,” asserted Matthew Panizzon, Ph.D. who is an assistant adjunct lecturer in neuropsychology at UCSD and the study’s principal investigator, in an announcement. Regarding the 3 to 5 percent of Americans who have persistent migraine — that’s 15 or more headache days a month for more than 3 months — it’s a severe quality of life problem.
